Demyelination and remyelination of the caudal cerebellar peduncle of adultrats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study
Rh. Woodruff et Rjm. Franklin, Demyelination and remyelination of the caudal cerebellar peduncle of adultrats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study, GLIA, 25(3), 1999, pp. 216-228
Experimentally induced demyelination due to the direct injection of gliotox
ic agents has provided powerful models for studying the biology of remyelin
ation. For the most part, these models have involved injection into white m
atter tracts of the spinal cord. However, the spinal cord has a number of l
imitations, such as the size of lesions that it is possible to make and its
unsuitability for long-term direct cannulation for the delivery of putativ
e remyelination-enhancing agents. In this study, we describe the natural hi
story of three new models of demyelination/remyelination based on the stere
otaxic injection of three gliotoxins: lysolecithin, ethidium bromide, and a
combination of anti-galactocerebroside antibody and complement (GalC-ab/co
mp) into the caudal cerebellar peduncle of adult rats. All three agents pro
duced large areas of demyelination with minimal axonal damage, which underg
o extensive remyelination. Ethidium bromide- and GalC-ab/comp-induced lesio
ns remyelinated more slowly than those induced by lysolecithin. The contrib
ution to the remyelination of the lesion by Schwann cells reflects the degr
ee of astrocyte damage incurred within the demyelinated area and is greates
t for ethidium bromide-induced demyelination. These new models not only pro
vide further insights into the mechanisms of CNS remyelination but also pro
vide a valuable new resource for addressing a series of key issues relevant
to current efforts to promote CNS remyelination either by the enhancement
of intrinsic processes or by the transplantation of myelinogenic cells. (C)
1999 Wiley-Liss, Inc.